Y. Lassere

发表

Phase I trial of combined irinotecan and oxaliplatin given every three weeks to patients with metastatic colorectal cancer

E. Saad, R. Pazdur, R. Wolff, 2004, Investigational New Drugs.

Case Studies in Metastatic Colorectal Cancer

R. Wickham, P. Viale, C. Viele, 2007 .

Phase I study to determine the safety and pharmacokinetics of oral administration of TAS‐102 in patients with solid tumors

M. Fukushima, D. Hong, J. Abbruzzese, 2006, Cancer.

Phase II trial of uracil and tegafur plus oral leucovorin: an effective oral regimen in the treatment of metastatic colorectal carcinoma.

J. Ajani, R. Pazdur, J. Abbruzzese, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I trial of Uracil-Tegafur (UFT) plus oral leucovorin: 14-day schedule

R. Pazdur, D. Ho, Y. Lassere, 2004, Investigational New Drugs.

Phase I and pharmacokinetic study of exatecan mesylate (DX-8951f): a novel camptothecin analog.

J. Lee, R. Pazdur, P. Hoff, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I trials of uracil‐tegafur (UFT) using 5 and 28 day administration schedules: demonstration of schedule‐dependent toxicities

R. Pazdur, D. Ho, Y. Lassere, 1996, Anti-cancer drugs.

Tegafur/uracil + calcium folinate in colorectal cancer: double modulation of fluorouracil.

R. Pazdur, P. Hoff, Y. Lassere, 1999, Drugs.

Phase I study with pharmacokinetics of S-1 on an oral daily schedule for 28 days in patients with solid tumors.

J. Ajani, E. Saad, R. Pazdur, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1-(2'-tetrahydrofuryl)-5-fluorouracil.

R. Pazdur, D. Ho, N. Brown, 1998, Clinical Cancer Research.

Tegafur/Uracil + Calcium Folinate in Colorectal Cancer

R. Pazdur, P. Hoff, Y. Lassere, 2012, Drugs.

Phase I and pharmacokinetic study of 3′-C-ethynylcytidine (TAS-106), an inhibitor of RNA polymerase I, II and III,in patients with advanced solid malignancies

M. Thomas, J. Abbruzzese, E. Rowinsky, 2012, Investigational New Drugs.

Phase II trial of docetaxel (Taxotere) in metastatic colorectal carcinoma.

J. Ajani, B. Levin, R. Pazdur, 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase I trial of uracil-tegafur (UFT) plus oral leucovorin: 28-day schedule.

R. Pazdur, D. Ho, Y. Lassere, 1998, Cancer investigation.

Management of hand-foot syndrome in patients treated with capecitabine (Xeloda).

P. Hoff, Y. Lassere, 2004, European journal of oncology nursing : the official journal of European Oncology Nursing Society.

A phase I study to determine the safety and pharmacokinetics of intravenous administration of TAS-106 once per week for three consecutive weeks every 28 days in patients with solid tumors.

M. Thomas, J. Abbruzzese, C. Meyers, 2012, Anticancer research.

The ABCs of Colorectal Cancer

R. Wickham, Y. Lassere, 2007 .

Phase II study of capecitabine in patients with fluorouracil-resistant metastatic colorectal carcinoma.

D. Samid, R. Pazdur, J. Abbruzzese, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I study of preoperative oral uracil and tegafur plus leucovorin and radiation therapy in rectal cancer.

E. Saad, R. Pazdur, J. Skibber, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Oral uracil and Ftorafur plus leucovorin: pharmacokinetics and toxicity in patients with metastatic cancer

R. Pazdur, Y. Rustum, N. Meropol, 2000, Cancer Chemotherapy and Pharmacology.

Phase I S tudy o f P reoperative O ral U racil a nd T egafur Plus L eucovorin a nd R adiation T herapy i n R ectal C ancer

E. Saad, R. Pazdur, J. Skibber, 2000 .

A phase II study of UFT with leucovorin administered as a twice daily schedule in the treatment of patients with metastatic colorectal cancer

S. Kopetz, R. Wolff, J. Abbruzzese, 2008, British Journal of Cancer.

Preoperative UFT and calcium folinate and radiotherapy in rectal cancer.

R. Pazdur, J. Skibber, N. Janjan, 1999, Oncology.